Details for 2019208417

Up to date per 01.04.2026

Actions

Title / Product Name

DOSIERSCHEMA FÜR ANTI-BCMA-WIRKSTOFFE

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2019208417

EP Publication Number

3819007

E-Number

1701468

Language

PCT Number

Publication Date

12.05.2021 A

10.07.2024 B1

Registration Date

10.07.2024

AT Publication Date

15.07.2024

Application Date

11.11.2019

Registration Number

Priorities

IPC

A61K 39/00 20060101AFI20230809BHEP

Maximum Duration of Protection

11.11.2039

Owner

Amgen Research (Munich) GmbHStaffelseestrasse 2 81477 MünchenDE

Amgen Inc.One Amgen Center Drive Thousand Oaks, CA 91320US

Representative

No representatives present

Inventor

Stieglmaier, Juliac/o Amgen Research (Munich) GmbH Staffelseestrasse 2 81477 MünchenDE

Huber, Birgitc/o Amgen Research (Munich) GmbH Staffelseestrasse 2 81477 MünchenDE

Minella, Alexanderc/o Amgen Inc One Amgen Center Drive Thousand Oaks, CA 91320US

Upreti, Vijayc/o Amgen Inc One Amgen Center Drive Thousand Oaks, CA 91320US

Information about Fees